‼️UNGLAUBLICH‼️
Die Firma Echelon. Inc, die diese Nano Lipide für Biontech/Pfizer herstellt, schreibt:
"...diese Lipide werden im BioNTech Impfstoff "BNT162b2" eingesetzt, sind aber nicht für die Verwendung am/im Menschen zugelassen sondern ausschließlich für Forschungszwecke."

ALC-0315 is an ionizable lipid which has been used to form lipid nanoparticles for delivery of RNA.ALC-0315 is one of the components in the BNT162b2 vaccine against SARS-CoV-2 in addition to ALC-0159, DSPC, cholesterol.This product is for research use only and not for human use."
https://t.co/rSOxRFTZwH
https://t.co/gi40e7mUqI

https://t.co/3yAElKnXgs

https://t.co/QXYZbFxHRq

https://t.co/Nb0q026Zvj

You May Also Like

Recently, the @CNIL issued a decision regarding the GDPR compliance of an unknown French adtech company named "Vectaury". It may seem like small fry, but the decision has potential wide-ranging impacts for Google, the IAB framework, and today's adtech. It's thread time! 👇

It's all in French, but if you're up for it you can read:
• Their blog post (lacks the most interesting details):
https://t.co/PHkDcOT1hy
• Their high-level legal decision: https://t.co/hwpiEvjodt
• The full notification: https://t.co/QQB7rfynha

I've read it so you needn't!

Vectaury was collecting geolocation data in order to create profiles (eg. people who often go to this or that type of shop) so as to power ad targeting. They operate through embedded SDKs and ad bidding, making them invisible to users.

The @CNIL notes that profiling based off of geolocation presents particular risks since it reveals people's movements and habits. As risky, the processing requires consent — this will be the heart of their assessment.

Interesting point: they justify the decision in part because of how many people COULD be targeted in this way (rather than how many have — though they note that too). Because it's on a phone, and many have phones, it is considered large-scale processing no matter what.